Rucaparib camsylate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rucaparib camsylate, covering 2025-06-12 to 2025-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency [Phase 2]